Effects of testosterone and vitamin D on fall risk in pre-frail hypogonadal men: a factorial design RCT
Objective: To test whether transdermal testosterone at a dose of 75 mg per day and/or monthly 24'000 IU Vitamin D reduces the fall risk in pre-frail hypogonadal men aged 65 and older. Design: 2 × 2 factorial design randomized controlled trial, follow up of 12 months. Methods: Hypogonadism was d...
Saved in:
Main Authors: | Heike A. Bischoff-Ferrari (Author), Melanie Kistler-Fischbacher (Author), Stephanie Gaengler (Author), Thomas Münzer (Author), Bess Dawson-Hughes (Author), Wei Lang (Author), Robert Theiler (Author), Andreas Egli (Author), E. John Orav (Author), Gregor Freystaetter (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adherence to the MIND diet and the odds of mild cognitive impairment in generally healthy older adults: The 3-year DO-HEALTH study
by: Roman Sager, et al.
Published: (2024) -
Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
by: Maurício de Almeida Ferreira, et al.
Published: (2022) -
Testosterone versus hCG in Hypogonadotropic Hypogonadism - Comparing Clinical Effects and Evaluating Current Practice
by: Swashti Agarwal MD, et al.
Published: (2020) -
Testosterone Therapy for Late-Onset Hypogonadism: A Clinical, Biological, and Analytical Approach Using Compounded Testosterone 0.5-20% Topical Gels
by: Daniel Banov, et al.
Published: (2024) -
Onset of vitiligo in a patient with acquired secondary hypogonadism under treatment with testosterone gel 2%: inside the pathogenesis,
by: Giovanni Paolino, et al.
Published: (2020)